To be very blunt, very few of the people who have written about this study so far, are as affected by this study than I am. I’m the closest to the demographic — being Type 2.
Quoted from http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2551:
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
Here’s my take on it. Right now, my blood sugar is the worst it’s been in ages and it’s been that way for months. I’m about to move up my endo’s appointment if it doesn’t get better soon.
My blood sugar has been bouncing up and down and has been in the 200’s most of the day. This affects my day to day living:
My vision is blurred. I am very cranky and hard to get along with. I say things I don’t mean, or at least wouldn’t say if I was in my normal state. I’m exhausted most of the time. I am not sleeping well. I am hungry all the time and crave food.
So I’m trying to get back to my normal good control because I am SICK. Not sick enough to call in sick but certainly not well –and I’ve even said that to students two or three times this week.
So for me, tight control is the right thing. If it causes a major cardio vascular event, so be it, frankly I’m hoping for the sudden, major event that kills me, since I watched my dad die a slow and often painful death.
Oh, yeah, and I’m depressed too….